Previous 10 | Next 10 |
Most companies don't comment on outside reports. Sorrento Therapeutics ' (NASDAQ: SRNE) President and CEO Henry Ji even says that's generally the biotech's policy. Then he went off on short sellers in an interview posted in a tweet by RagingBull yesterday afternoon. "I am giving them a fa...
Shares of Sorrento Therapeutics (NASDAQ: SRNE) were up 4.7% as of 10:33 a.m. EDT on Wednesday after rising as much as 14.9% earlier in the day. Why did the stock bounce back after plunging earlier this week ? Sorrento didn't report any news that would provide a catalyst. Instead, it appears...
August 26, 2020 Palm Beach, FL – August 26, 2020 – The worldwide response, both private and public, to finding a therapeutic and/or vaccine for the global pandemic has brought out the best in the global community. Contrary to historical comparable situations, it appe...
Tyme Technologies (NASDAQ: TYME ) +29% as oncology research reveals potential new oral therapy TYME-19 in the fight against COVID-19. More news on: Tyme Technologies, Inc., SCWorx Corp., Immunic, Inc., Stocks on the move, , Read more ...
Gainers: Cancer Genetics (NASDAQ: CGIX ) +142% . More news on: Cancer Genetics, Inc., iBio, Inc., Sonnet BioTherapeutics Holdings, Inc., Stocks on the move, , Read more ...
Onconova Therapeutics (NASDAQ: ONTX ) -71% after announcing topline results from Phase 3 INSPIRE trial. More news on: Onconova Therapeutics, Inc., Northern Dynasty Minerals Ltd., Odonate Therapeutics, Inc., Stocks on the move, , Read more ...
Following through on its letter of intent announced on July 24, Sorrento Therapeutics (NASDAQ: SRNE ) inks a formal merger agreement with SmartPharm Therapeutics. More news on: Sorrento Therapeutics, Inc., Healthcare stocks news, Merger & acquisition news, Stocks on the move, ...
The combination of SmartPharm’s Gene Mab™ gene-encoded in vivo expression system and Sorrento’s SARS-CoV-2 neutralizing antibodies may potentially provide longer-acting, single injection protection against COVID-19. Beyond COVID-19, the synergies between Sorrent...
Shares of Sorrento Therapeutics (NASDAQ: SRNE) fell on Wednesday after the biopharmaceutical company fired its chief financial officer. By the close of trading, Sorrento's stock was down 9.9%. After the market close on Tuesday, Sorrento disclosed in a Securities and Exchange Commission...
After the market closed on Tuesday, Sorrento Therapeutics (NASDAQ: SRNE) disclosed in an SEC filing that it fired Executive Vice President and Chief Financial Officer Jiong Shao, effective immediately. Shares of the stock down around 11.7% at 1:29 pm on Wednesday. Najjam Asghar, formerly So...
News, Short Squeeze, Breakout and More Instantly...
Sorrento Therapeutics Inc. Company Name:
SRNE Stock Symbol:
NASDAQ Market:
Sorrento Therapeutics Inc. Website:
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...
Gelesis Holdings, Inc. (GLSHQ) is expected to report for Q1 2024 EVmo Inc (YAYO) is expected to report for Q1 2024 Chiba Bank Ltd. ADR (CHBAY) is expected to report for Q4 2024 Spark Networks SE (LOVLQ) is expected to report for Q1 2024 ToughBuilt Industries Inc. (TBLT) is expecte...
Smart Share Global Limited (EM) is expected to report for Q1 2024 American Rebel Holdings Inc. (AREB) is expected to report for Q1 2024 First Republic Bank (San Francisco, California) (FRCB) is expected to report for Q1 2024 Spark Networks SE (LOVLQ) is expected to report for Q1 2024 ...